Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. - Wikidata - awgldk - TriplyDB

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

http://www.wikidata.org/entity/Q34652138

about

Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis GAS, a new glutamate-rich protein, interacts differentially with SRCs and is involved in oestrogen receptor function Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Therapeutic options for management of endometrial hyperplasia Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen Environmental toxicants, epigenetics, and cancer Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells Metabolomic profiling unravels DNA adducts in human breast that are formed from peroxidase mediated activation of estrogens to quinone methides A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis.CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis Functional variants at the 21q22.3 locus involved in breast cancer progression identified by screening of genome-wide estrogen response elements.Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors.Estrogen receptor mutations and their role in breast cancer progression Biomarkers in endometrial cancer: Possible clinical applications (Review)APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.Maternal smoking impacts key biological pathways in newborns through epigenetic modification in Utero.Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling Estrogen-responsive genes encoding egg yolk proteins vitellogenin and apolipoprotein II in chicken are differentially regulated by selective estrogen receptor modulators.Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases.Bioactivation of Selective Estrogen Receptor Modulators (SERMs)Preclinical development of a neutral, estrogen receptor-targeted, tridentate 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers.

P2860

Q21562188-881A0BE2-387D-4D5A-8BB5-F3BE36356F05 Q24304823-4C076112-A34E-493F-9F29-A4954DA672AA Q24309520-AA4FE927-7F3D-4369-B519-095F8122439C Q24312025-4F7C9035-C522-41E2-96F0-12234D1AA4E7 Q24318720-3E5874D9-885D-4C0E-B71E-EABA9496BBC9 Q24318938-314B7C14-6BDD-4730-B42A-74168BEF328E Q24621003-05DEF818-3B3C-43FA-A258-9D8317495695 Q26783569-DA6E8028-2BBE-4C6F-94CD-2D03BCDEBF08 Q27687650-63EB9ABF-E0C1-4454-8BF8-E83275FB03D0 Q28281218-7F970A6C-EFFE-46D8-AD26-5A9FB2E70DF5 Q28385295-FF63044A-0CB9-444F-9761-FA7331408C8D Q28477353-1ED43323-ACDE-47B0-8E6A-F8A50C1F3331 Q28533703-3DDCFE89-DCF5-4310-94FD-AE98D9A6582A Q30535835-59B4856F-B6ED-49F5-B3FF-207A04EB5C4D Q33579159-4DBFCAB5-AF37-49A4-BA0F-F73564290A34 Q33584903-CD7641F0-31D6-46D9-8DD1-60BF6609D5FD Q33692377-2CA0F115-92C3-4905-B5AB-A9215EADDD2F Q33747888-98DDE46C-C34F-4088-AC7F-D8E0D5F31A93 Q33829461-A23C4199-EF88-4BF3-8DCD-3F08E10CC7D2 Q33858186-BBDDC9A1-477B-4643-8CF5-CD999859AF4C Q33894047-74124C1F-67DE-4FCA-B646-740EF2F85E0B Q34089736-F2F0CE95-91D5-419B-9CDE-982BBF9AD82B Q34121216-99070E6E-F9F9-4168-8418-7B7907CE8B63 Q34628232-DCD4A9C9-2C94-480C-A08F-651E96F7448B Q34727321-1510A843-1EAF-4CD0-9B04-185184EC9618 Q34938177-7BDA6E02-0ECB-4198-9E2B-6F37A0B8FE26 Q35000343-5D5C4B1B-3EC5-4A19-899D-DB4735AB29A2 Q35029561-042377FB-2878-492F-AC91-30CB85910A31 Q35593300-D608AEFB-9574-4AE5-9A1F-3D474124BED4 Q35599448-54FB43CE-21BD-44CC-8BF9-E5D145D4C339 Q36084326-83396A25-ED3F-4FA9-B58E-6376109B5689 Q36133842-FD027FBB-1756-4201-BE11-5A36658C0CA8 Q36167236-47BA0F6F-4292-4BCF-9816-E5F26E9F2E9D Q36171217-112AE987-8216-419A-8DFF-C2EB7168E688 Q36204093-BFE658E9-7D8A-4D90-9839-7D6BD3AD1441 Q36212729-76A0DC9D-F64A-4041-B2DE-79657AB1BA0C Q36437107-F07BF1A1-DF58-4B35-9729-28BB3220D940 Q36493879-50C81E74-DA3E-4695-98E5-D62CFF2214F9 Q36595120-922B77CA-FD88-4EA8-ACCA-A00E993A157F Q36731191-69DEFF31-6D3D-4261-80DC-9CED2EB14CDA

P2860

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

http://www.wikidata.org/entity/Q34652138

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@ast

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@en

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@nl

type

label

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@ast

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@en

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@nl

prefLabel

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@ast

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@en

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@nl

P1433

Q34652138-CCD9531F-B0A7-4A33-9634-4ED9AF296F46

P1476

Q34652138-5CA7A681-C593-42F4-9E3B-A20E8D261B45

P2093

Q34652138-7A31BBC8-4009-4527-8FFE-70D28FBB074F

P2860

Q34652138-056828D5-E6FD-4425-837C-0562CC394B39

Q34652138-0624724D-6EB7-42FD-A854-E637ECA23663

Q34652138-0B1944A9-2DF4-4F24-B222-ABA736A2CB5A

Q34652138-0DF3665F-A149-421D-9EFB-BE60C24D2DED

Q34652138-0EC2804F-8FA0-42AD-A5CA-FAA6CF708F69

Q34652138-0F373EBE-56C7-4C07-AA0D-F0DF47C8D1C8

Q34652138-103D9E40-2145-427D-BB1C-ACA361F8A6EC

Q34652138-1A515033-0EE7-483D-9413-ECA0C6E55617

Q34652138-1ACA3C42-223E-48F2-9B1E-F71A805D5040

Q34652138-1AE27EDF-2FA3-47D7-80DE-8F86D4B4FC32

P2888

Q34652138-AD5BB62C-AA8A-4D99-B4B6-2B08D5BE0DAF

P304

Q34652138-98029FE3-F264-481F-B011-73E0A9C23F9F

P31

Q34652138-8CC33BEA-3005-4174-9E70-420BE1E21233

Q34652138-c6228eec-146d-491a-8990-d7208fa660f2

P356

Q34652138-DF9CBD2B-ADED-4417-B3C1-EB9D696CCCA0

P407

Q34652138-818F47E7-DB31-498B-84B3-17B5C8C1112E

P433

Q34652138-C6A5E8C4-DE07-423D-8A58-3416263AD0DC

P478

Q34652138-057B749F-5BC7-4449-9BC3-4B92037F6650

P577

Q34652138-B56ABE31-D079-42DC-A176-D90CF2C5112B

P5875

Q34652138-BF01A80A-5B01-4A6B-A4F9-49140DF00F49

P6179

Q34652138-77491019-6B8C-4E98-8F0B-53A7D0530E09

P698

Q34652138-F398EA71-C41E-416B-AB6D-900125FE7693

P356

P1433

Nature Reviews Cancer

P1476

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis.

@en

P2093

Yongfeng Shang

http://www.w3.org/2001/XMLSchema#string

P2860

Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements

Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human

Isolation of estrogen-responsive genes with a CpG island library

A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474

Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels

Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus

Structural insights into the mode of action of a pure antiestrogen

Molecular basis of agonism and antagonism in the oestrogen receptor

Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains

P2888

P304

360-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRC1879

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7148176

http://www.w3.org/2001/XMLSchema#string

P6179

1009898631

http://www.w3.org/2001/XMLSchema#string

P698

16633364

http://www.w3.org/2001/XMLSchema#string